Hormone Sensitive Prostate Cancer Market size and Key Trends in terms of volume and value 2016-2026
Prostate cancer is a general term used for diseased condition in which abnormal cells grow and invade in uncontrolled manner in the prostate. Prostate cancer inhibits production of male sex hormones (i.e. androgens) and ultimately blocks the action of androgen. The androgen is also responsible for the growth of prostate cancer. Androgen binds with the receptors and stimulates the expression of specific genes that would be responsible for prostate cancer. However, androgen suppression hormonal therapies are commonly used for the treatment of this cancer. These therapies acts by reducing the production of androgen by the testicles or by blocking the action of androgen in the body. There is an opportunity for the growth of hormone sensitive prostate cancer owing to the rapidly aging population which is the major cause of prostate cancer.
Prostate cancer is a general term used for diseased condition in which abnormal cells grow and invade in uncontrolled manner in the prostate. Prostate cancer inhibits production of male sex hormones (i.e. androgens) and ultimately blocks the action of androgen. The androgen is also responsible for the growth of prostate cancer. Androgen binds with the receptors and stimulates the expression of specific genes that would be responsible for prostate cancer. However, androgen suppression hormonal therapies are commonly used for the treatment of this cancer. These therapies acts by reducing the production of androgen by the testicles or by blocking the action of androgen in the body. There is an opportunity for the growth of hormone sensitive prostate cancer owing to the rapidly aging population which is the major cause of prostate cancer.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Hormone</strong> <strong>Sensitive</strong><br />
<strong>Prostate</strong> <strong>Cancer</strong> <strong>Market</strong><br />
Share, Global <strong>Trends</strong>,<br />
Analysis, Research, Report,<br />
Opportunities,<br />
Segmentation <strong>and</strong> Forecast,<br />
<strong>2016</strong><br />
Future <strong>Market</strong> Insights<br />
www.futuremarket<strong>in</strong>sights.com<br />
sales@futuremarket<strong>in</strong>sights.com
Future <strong>Market</strong> Insights (FMI) is a premier provider <strong>of</strong> syndicated research reports, custom research reports, <strong>and</strong> consult<strong>in</strong>g<br />
services. We deliver a complete packaged solution, which comb<strong>in</strong>es current market <strong>in</strong>telligence, statistical anecdotes,<br />
technology <strong>in</strong>puts, valuable growth <strong>in</strong>sights, aerial view <strong>of</strong> the competitive framework, <strong>and</strong> future market trends.<br />
We provide research services at a global as well as regional level; key regions <strong>in</strong>clude GCC, ASEAN, <strong>and</strong> BRIC.<br />
Our <strong>of</strong>fer<strong>in</strong>gs cover a broad spectrum <strong>of</strong> <strong>in</strong>dustries <strong>in</strong>clud<strong>in</strong>g Chemicals, Materials, Energy, Technology, Healthcare, <strong>and</strong><br />
Retail.<br />
We have a global presence with delivery centers across India specializ<strong>in</strong>g <strong>in</strong> provid<strong>in</strong>g global research reports <strong>and</strong> country<br />
research reports. FMI is headquartered out <strong>of</strong> London, U.K., with a state-<strong>of</strong>-the-art delivery center located <strong>in</strong> Pune, India.<br />
We comb<strong>in</strong>e our knowledge <strong>and</strong> learn<strong>in</strong>g from every corner <strong>of</strong> the world to distill it to one th<strong>in</strong>g – the perfect solution for<br />
our client.<br />
Research Capabilities<br />
• Customized Research<br />
• Syndicated Research<br />
• Investment Research<br />
• Social Media Research<br />
Sector Coverage<br />
• Automotive <strong>and</strong> Transportation<br />
• Electronics, Semiconductor, <strong>and</strong> ICT<br />
• Retail <strong>and</strong> Consumer Products<br />
• Industrial Automation <strong>and</strong> Equipment<br />
• Chemicals & Materials<br />
• Food <strong>and</strong> Beverages<br />
• Services <strong>and</strong> Utilities<br />
• Energy, M<strong>in</strong><strong>in</strong>g, Oil, <strong>and</strong> Gas<br />
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Subscription Information<br />
For detailed subscription <strong>in</strong>formation please contact<br />
Hari. T (Sr. Manager - Global Bus<strong>in</strong>ess Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarket<strong>in</strong>sights.com
Report Description<br />
<strong>Prostate</strong> cancer is a general term used for diseased condition <strong>in</strong> which abnormal cells<br />
grow <strong>and</strong> <strong>in</strong>vade <strong>in</strong> uncontrolled manner <strong>in</strong> the prostate. <strong>Prostate</strong> cancer <strong>in</strong>hibits<br />
production <strong>of</strong> male sex hormones (i.e. <strong>and</strong>rogens) <strong>and</strong> ultimately blocks the action <strong>of</strong><br />
<strong>and</strong>rogen. The <strong>and</strong>rogen is also responsible for the growth <strong>of</strong> prostate cancer. Androgen<br />
b<strong>in</strong>ds with the receptors <strong>and</strong> stimulates the expression <strong>of</strong> specific genes that would be<br />
responsible for prostate cancer. However, <strong>and</strong>rogen suppression hormonal therapies are<br />
commonly used for the treatment <strong>of</strong> this cancer. These therapies acts by reduc<strong>in</strong>g the<br />
production <strong>of</strong> <strong>and</strong>rogen by the testicles or by block<strong>in</strong>g the action <strong>of</strong> <strong>and</strong>rogen <strong>in</strong> the<br />
body. There is an opportunity for the growth <strong>of</strong> hormone sensitive prostate cancer ow<strong>in</strong>g<br />
to the rapidly ag<strong>in</strong>g population which is the major cause <strong>of</strong> prostate cancer.<br />
<strong>Hormone</strong> <strong>Sensitive</strong> <strong>Prostate</strong> <strong>Cancer</strong> <strong>Market</strong>: Drivers <strong>and</strong> Restra<strong>in</strong>ts<br />
Increas<strong>in</strong>g <strong>in</strong>cidence <strong>of</strong> hormone sensitive prostate cancers <strong>and</strong> availability <strong>of</strong> various<br />
treatment modalities like surgery, radiation therapy <strong>and</strong> cryosurgery are the major factors<br />
driv<strong>in</strong>g the growth <strong>of</strong> hormone sensitive prostate cancer treatment market globally. The<br />
driv<strong>in</strong>g factor <strong>of</strong> hormone sensitive prostate cancer market is the. Advancement <strong>in</strong><br />
technology, personalized medic<strong>in</strong>e, cost effective treatment procedures are few other<br />
factors expected provide boost to global hormone sensitive prostate cancer treatment<br />
market. However, limited commercially availability drugs <strong>and</strong> treatments for this cancer is<br />
the challenge restra<strong>in</strong><strong>in</strong>g the growth <strong>of</strong> global hormone sensitive prostate cancer<br />
treatment market.
Report Description<br />
Request free sample Report: http://www.futuremarket<strong>in</strong>sights.com/reports/sample/repgb-1375<br />
<strong>Hormone</strong> <strong>Sensitive</strong> <strong>Prostate</strong> <strong>Cancer</strong> <strong>Market</strong>: Segmentation<br />
The global hormone sensitive prostate cancer market has been segmented on the basis<br />
<strong>of</strong> treatment, end use <strong>and</strong> geography.<br />
Based on treatment, the global hormone sensitive prostate cancer market is segmented<br />
<strong>in</strong>to:<br />
• Androgen Ablation Therapy<br />
• Anti-<strong>and</strong>rogens<br />
• Chemotherapy<br />
• Targeted Therapy<br />
• Cryotherapy<br />
Based on end user type, the global hormone sensitive prostate cancer market is<br />
segmented <strong>in</strong>to:<br />
• Hospitals<br />
• Cl<strong>in</strong>ics<br />
• <strong>Cancer</strong> Rehabilitation Centers
Report Description<br />
Request for TOC: http://www.futuremarket<strong>in</strong>sights.com/toc/rep-gb-1375<br />
<strong>Hormone</strong> <strong>Sensitive</strong> <strong>Prostate</strong> <strong>Cancer</strong> <strong>Market</strong>: Regional Overview<br />
Geographically, the global hormone sensitive prostate cancer market is classified <strong>in</strong>to<br />
regions namely, North America, Lat<strong>in</strong> America, Western Europe, Eastern Europe, Asia-<br />
Pacific, Japan, Middle East <strong>and</strong> Africa.North America takes the largest share <strong>of</strong> global<br />
hormone sensitive cancer treatment market followed by Europe. The global hormone<br />
sensitive prostate cancer treatment market is expected to grow <strong>in</strong> future due to<br />
<strong>in</strong>creas<strong>in</strong>g <strong>in</strong>vestment by mult<strong>in</strong>ational companies <strong>in</strong> cancer research.<br />
<strong>Hormone</strong> <strong>Sensitive</strong> <strong>Prostate</strong> <strong>Cancer</strong> <strong>Market</strong>: <strong>Key</strong> Players<br />
Some <strong>of</strong> the key players <strong>in</strong> hormone sensitive prostate cancer market are Novartis<br />
Pharmaceuticals, Merc & Co., Inc., Bristol-Myers, Dendreon Corporation, GlaxoSmithKl<strong>in</strong>e<br />
plc., Ferr<strong>in</strong>g International Center S.A., Roche group, Celgen Corporation, Amgen Inc., Teva<br />
pharmaceutical Industries Ltd., Bayer AG, <strong>and</strong> Pfizer Inc.<br />
Browse full report: http://www.futuremarket<strong>in</strong>sights.com/reports/hormone-sensitiveprostate-cancer-market
Thank You!<br />
To know more about us, please visit our website:<br />
www.futuremarket<strong>in</strong>sights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarket<strong>in</strong>sights.com<br />
For other queries contact: Mr. Sudip Saha<br />
Future <strong>Market</strong> Insights: 616 Corporate Way, Suite 2-9018,<br />
Valley Cottage, NY 10989, United States<br />
T: +1-347-918-3531 | D: +1-845-579-5705
Change language